Summary: MAPS-sponsored researcher Marcela Ot’alora speaks at the Interdisciplinary Conference on Psychedelics Research (ICPR) about her experience providing MDMA-assisted psychotherapy as a treatment for posttraumatic stress disorder (PTSD) in Boulder, Colorado.
Originally appearing here.
Marcela Ot’alora G. was born and raised in Colombia, S.A. and now lives in Boulder, Colorado, USA. She has a MA in Transpersonal Psychology and a MFA in Fine Arts. Marcela is dedicated to the treatment and research of trauma, first through art and later through the use of MDMA-assisted Psychotherapy. She worked as a co-therapist in the first government approved MDMA-assisted psychotherapy study in Madrid Spain and is the Principal Investigator of the Phase II MDMA-assisted psychotherapy study in Boulder, Colorado.
Sponsored by the Multidisciplinary Association for Psychedelic studies (MAPS), this Phase II clinical pilot study explores the safety and efficacy of administering MDMA in conjunction with Psychotherapy to participants with treatment resistant Posttraumatic Stress Disorder (PTSD).
Evidence in completed phase II trials, and preliminary findings in this phase II trial show promising results in reducing PTSD symptoms with a good safety profile.
Given the limited effectiveness of current available medications and therapeutic strategies, MDMA-assisted psychotherapy holds promise as a treatment option. This talk will focus on methodology as well as individual participant experiences.